Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability and determine the
recommended dosing for the treatment in patients with advanced pancreatic cancer after
fist-line Gemcitabine treatment failure.